Wells Fargo’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,391
| Closed | -$2.59K | – | 6675 |
|
|
2024
Q4 | $2.59K | Hold |
4,391
| – | – | ﹤0.01% | 5652 |
|
|
2024
Q3 | $3.46K | Hold |
4,391
| – | – | ﹤0.01% | 5574 |
|
|
2024
Q2 | $5.58K | Sell |
4,391
-174
| -4% | -$221 | ﹤0.01% | 5480 |
|
|
2024
Q1 | $6.35K | Buy |
4,565
+2,179
| +91% | +$3.03K | ﹤0.01% | 5456 |
|
|
2023
Q4 | $3.79K | Buy |
2,386
+34
| +1% | +$54 | ﹤0.01% | 5554 |
|
|
2023
Q3 | $3.34K | Buy |
2,352
+4
| +0.2% | +$6 | ﹤0.01% | 5642 |
|
|
2023
Q2 | $3.73K | Buy |
2,348
+37
| +2% | +$59 | ﹤0.01% | 5809 |
|
|
2023
Q1 | $1.94K | Buy |
2,311
+10
| +0.4% | +$8 | ﹤0.01% | 5907 |
|
|
2022
Q4 | $3.27K | Buy |
2,301
+250
| +12% | +$355 | ﹤0.01% | 5561 |
|
|
2022
Q3 | $4K | Hold |
2,051
| – | – | ﹤0.01% | 5667 |
|
|
2022
Q2 | $4K | Buy |
2,051
+4
| +0.2% | +$8 | ﹤0.01% | 5828 |
|
|
2022
Q1 | $6K | Buy |
2,047
+2,011
| +5,586% | +$5.89K | ﹤0.01% | 6082 |
|
|
2021
Q4 | $0 | Buy |
36
+1
| +3% | – | ﹤0.01% | 7357 |
|
|
2021
Q3 | $0 | Sell |
35
-1
| -3% | – | ﹤0.01% | 7264 |
|
|
2021
Q2 | $0 | Buy |
36
+12
| +50% | – | ﹤0.01% | 7145 |
|
|
2021
Q1 | $0 | Buy |
+24
| New | – | ﹤0.01% | 7071 |
|